Pharma Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Collaborations
Collaboration formed to provide primate-human gene expression and SNP assays
February 27th, 2006
BioTrove and RxGen PrimaTox Inc. (RxP) announced a collaboration to provide gene expression and SNP assays designed to work in primates and humans, bridging the gap between preclinical and clinical drug safety analysis. RxP's Tox-Optimum gene expression assays include the most toxicologically relevant genes, probes for which have been optimized to work in samples from either humans or nonhuman primates. The assays have been designed to work exclusively on BioTrove's OpenArray platform, which allows simultaneous quantitative analysis of several thousand genes. BioTrove will provide the OpenArray platform and will manufacture the Tox-Optimum assays to RxP's...
Source: Pharma Business Week (2006-02-27)
|
